Locally Advanced / Metastatic Solid Tumors
11 clinical trials · Condition
◉ Watch Locally Advanced / Metastatic Solid Tumors
| Record | Firm | Date |
|---|---|---|
| HY-0102 Monotherapy in Patients With Locally Advanced/Metastatic Solid Tumours (NCT04914351) | Shanghai HyaMab Biotech Co.,Ltd. | 2022-05-03 |
| PE0116 Injection in Treatment of Patients With Advanced Solid Tumours (NCT05800249) | Shanghai HyaMab Biotech Co.,Ltd. | 2021-03-08 |
| A Phase 1/2 Study of TY101 for Locally Advanced /Metastatic Solid Tumors and Relapsed or Refractory Lymphomas (NCT04458389) | Tayu Huaxia Biotech Medical Group Co., Ltd. | 2020-12-07 |
| Safety Study of BJ-001, an IL-15 Fusion Protein, for Locally Advanced/Metastatic Solid Tumors (NCT04294576) | BJ Bioscience, Inc. | 2019-12-04 |
| A Phase I Study of MK-2206 in Combination With Standard Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors (MK-2206-003) (NCT00848718) | Merck Sharp & Dohme LLC | 2009-03-17 |
Track Locally Advanced / Metastatic Solid Tumors automatically
Every clearance here is in the API, with alerts when new ones post.